BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19298540)

  • 1. Chromium picolinate inhibits resistin secretion in insulin-resistant 3T3-L1 adipocytes via activation of amp-activated protein kinase.
    Wang YQ; Dong Y; Yao MH
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):843-9. PubMed ID: 19298540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK.
    Wang YQ; Yao MH
    J Nutr Biochem; 2009 Dec; 20(12):982-91. PubMed ID: 19195868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and chromium picolinate induce translocation of CD36 to the plasma membrane through different signaling pathways in 3T3-L1 adipocytes, and with a differential functionality of the CD36.
    Wang Y; Van Oort MM; Yao M; Van der Horst DJ; Rodenburg KW
    Biol Trace Elem Res; 2011 Sep; 142(3):735-47. PubMed ID: 20721637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Carotene accumulation in 3T3-L1 adipocytes inhibits the elevation of reactive oxygen species and the suppression of genes related to insulin sensitivity induced by tumor necrosis factor-α.
    Kameji H; Mochizuki K; Miyoshi N; Goda T
    Nutrition; 2010; 26(11-12):1151-6. PubMed ID: 20097535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase.
    Huypens P; Quartier E; Pipeleers D; Van de Casteele M
    Eur J Pharmacol; 2005 Aug; 518(2-3):90-5. PubMed ID: 16039647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gly-Ala-Gly-Val-Gly-Tyr, a novel synthetic peptide, improves glucose transport and exerts beneficial lipid metabolic effects in 3T3-L1 adipoctyes.
    Kim ED; Kim E; Lee JH; Hyun CK
    Eur J Pharmacol; 2011 Jan; 650(1):479-85. PubMed ID: 20951125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the phosphatidylinositol 3'-kinase signaling pathway leads to decreased insulin-stimulated adiponectin secretion from 3T3-L1 adipocytes.
    Pereira RI; Draznin B
    Metabolism; 2005 Dec; 54(12):1636-43. PubMed ID: 16311098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoginkgetin enhances adiponectin secretion from differentiated adiposarcoma cells via a novel pathway involving AMP-activated protein kinase.
    Liu G; Grifman M; Macdonald J; Moller P; Wong-Staal F; Li QX
    J Endocrinol; 2007 Sep; 194(3):569-78. PubMed ID: 17761896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17β-estradiol induces an interaction between adenosine monophosphate-activated protein kinase and the insulin signaling pathway in 3T3-L1 adipocytes.
    Kim JY; Jo KJ; Kim BJ; Baik HW; Lee SK
    Int J Mol Med; 2012 Oct; 30(4):979-85. PubMed ID: 22825002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3'-kinase.
    Pereira RI; Leitner JW; Erickson C; Draznin B
    Life Sci; 2008 Nov; 83(19-20):638-43. PubMed ID: 18824177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes.
    Fasshauer M; Klein J; Neumann S; Eszlinger M; Paschke R
    Biochem Biophys Res Commun; 2001 Nov; 288(4):1027-31. PubMed ID: 11689013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extract of Cinnamomum cassia twigs inhibits adipocyte differentiation via activation of the insulin signaling pathway in 3T3-L1 preadipocytes.
    Han Y; Jung HW; Bae HS; Kang JS; Park YK
    Pharm Biol; 2013 Aug; 51(8):961-7. PubMed ID: 23627464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishing and identifying insulin resistance 3T3-L1 adipocytes cell model].
    Guo XN; Yang JT; Niu F; Zhang RX; Jia ZP
    Zhong Yao Cai; 2008 Feb; 31(2):258-61. PubMed ID: 18619274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes.
    Fasshauer M; Klein J; Neumann S; Eszlinger M; Paschke R
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1084-9. PubMed ID: 11798186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro.
    Lagathu C; Bastard JP; Auclair M; Maachi M; Kornprobst M; Capeau J; Caron M
    Antivir Ther; 2004 Dec; 9(6):911-20. PubMed ID: 15651750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent high glucose exacerbates the aberrant production of adiponectin and resistin through mitochondrial superoxide overproduction in adipocytes.
    Sun J; Xu Y; Deng H; Sun S; Dai Z; Sun Y
    J Mol Endocrinol; 2010 Mar; 44(3):179-85. PubMed ID: 20154025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine attenuates TNF-alpha induced changes in secretion of interleukin-6, plasminogen activator inhibitor-1 and adiponectin from 3T3-L1 adipocytes.
    Araki S; Dobashi K; Kubo K; Yamamoto Y; Asayama K; Shirahata A
    Life Sci; 2006 Nov; 79(25):2405-12. PubMed ID: 16952378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interfering effects of insulin, growth hormone and glucose on adipokine secretion.
    Wölfing B; Neumeier M; Buechler C; Aslanidis C; Schölmerich J; Schäffler A
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):47-52. PubMed ID: 17973209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes.
    Kudoh A; Satoh H; Hirai H; Watanabe T
    Life Sci; 2011 Jun; 88(23-24):1055-62. PubMed ID: 21514306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
    Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.